Middle East & Africa Medical Cyclotron Market

The medical cyclotron market in Middle East & Africa is expected to grow from US$ 5.97 million in 2022 to US$ 9.24 million by 2028; it is estimated to grow at a CAGR of 7.5% from 2022 to 2028.

The increasing acceptance of medical accelerators for cancer treatment and diagnosis is emerging as a prominent trend in the medical cyclotron market. With the growing awareness related to cancer prevention, the number of radiation scans is also on the rise. The growing demand for nuclear scans boosted the medical cyclotron market growth from 2021 to 2022. The demand for nuclear scans is due to the rising incidences and prevalence of cancer, heart disease, gastrointestinal, endocrine, and neurological disorders. Such diseases are diagnosed in comparatively early stages by using nuclear imaging equipment and other equipment. Strong radio waves are guided into specially shaped metal tubes called resonators in conventional particle accelerators. Further, many resonators have to be connected in series to bring particles to high energy levels, making new accelerators, in many cases, longer in size. As a result of this concern, experts are eagerly working on an alternative, i.e., plasma accelerators. In May 2021, an international research group made significant progress in developing compact plasma accelerators, which is considered a promising technology. Furthermore, with two complementary experiments, the team combined two different plasma technologies for the first time and built a novel hybrid accelerator. The concept can advance accelerator development and, in the long term, become the basis of highly brilliant X-ray sources for research and medicine. With this rising demand, these innovations are likely to make rapid progress in the medical diagnostics industry. Thus, the demand for medical cyclotrons is expected to rise in the coming years.

Middle East & Africa Medical Cyclotron Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Medical Cyclotron Market Segmentation   

The Middle East & Africa medical cyclotron market is segmented into type, capacity, end user, and country. Based on type, the market is bifurcated into ring cyclotron and azimuthally varying fields (AVF). The ring cyclotron segment held the larger share of the market in 2022. Based on capacity, the market is segmented into 10-12 MeV, 16-18 MeV, 19-24 MeV, and 24 MeV and above. In 2022, the 16-18 MeV segment held the largest share of the market. Based on end user, the market is categorized into hospitals, specialized clinics, pharmaceutical companies, and others. In 2022, the hospitals segment held the largest share of the market. Based on country, the Middle East & Africa medical cyclotron market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Further, South Africa held the largest share of the market in 2022.

A few of the key players operating in the Middle East & Africa medical cyclotron market are Advanced Cyclotron Systems; Best ABT Molecular Imaging, Inc; Best Cyclotron Systems, Inc.; General Electric Company; IBA; Ionetix Corporation; isoSolution Inc.; Siemens AG; and Sumitomo Heavy Industries, Ltd.